tiprankstipranks
Tenet Healthcare Corp. (CH:THC1)
NYSE:THC1
Switzerland Market

Tenet Healthcare (THC1) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

THC1 Analyst Ratings

Strong Buy
14Ratings
Strong Buy
13 Buy
1 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Tenet
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

THC1 Stock 12 Month Forecast

Average Price Target

$198.08
Based on 14 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $198.08 with a high forecast of $217.13 and a low forecast of $168.88. The average price target represents a change from the last price of .
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
Highest Price Target$217.13Average Price Target$198.08Lowest Price Target$168.88
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CH:THC1
RBC Capital
RBC Capital
CHF189.79
Buy
Reiterated
07/09/26
Tenet Healthcare (THC) Gets a Buy from RBC Capital
Bank of America Securities Analyst forecast on CH:THC1
Bank of America Securities
Bank of America Securities
Buy
Reiterated
07/08/26
Analysts Are Bullish on Top Healthcare Stocks: Tenet Healthcare (THC), Opus Genetics (IRD)
Barclays
CHF191.4CHF193
Buy
Reiterated
07/08/26
Tenet Healthcare price target raised to $240 from $238 at BarclaysTenet Healthcare price target raised to $240 from $238 at Barclays
TD Cowen
CHF187.38
Buy
Assigned
06/25/26
TD Cowen Remains a Buy on Tenet Healthcare (THC)
Morgan Stanley Analyst forecast on CH:THC1
Morgan Stanley
Morgan Stanley
CHF204.26
Buy
Reiterated
06/15/26
Analyst Maintains Buy on Tenet Healthcare, Reaffirming Unchanged $254 Price Target Amid Favorable Risk-Reward Setup
J.P. Morgan Analyst forecast on CH:THC1
J.P. Morgan
J.P. Morgan
CHF225.17CHF209.09
Buy
Reiterated
05/22/26
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
Robert W. Baird Analyst forecast on CH:THC1
Robert W. Baird
Robert W. Baird
CHF197.03CHF168.88
Hold
Reiterated
05/05/26
Tenet Healthcare price target lowered to $210 from $245 at BairdTenet Healthcare price target lowered to $210 from $245 at Baird
Stephens Analyst forecast on CH:THC1
Unknown Analyst
Stephens
Not Ranked
Stephens
CHF209.09
Buy
Reiterated
05/04/26
Stephens Remains a Buy on Tenet Healthcare (THC)
Truist Financial Analyst forecast on CH:THC1
Truist Financial
Truist Financial
CHF217.13
Buy
Reiterated
05/04/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Kymera Therapeutics (NASDAQ: KYMR)
Goldman Sachs Analyst forecast on CH:THC1
Goldman Sachs
Goldman Sachs
CHF213.11CHF202.65
Buy
Reiterated
05/03/26
Goldman Sachs Reaffirms Their Buy Rating on Tenet Healthcare (THC)
KeyBanc
CHF201.05CHF180.94
Buy
Reiterated
05/01/26
Tenet Healthcare price target lowered to $225 from $250 at KeyBancTenet Healthcare price target lowered to $225 from $250 at KeyBanc
Cantor Fitzgerald Analyst forecast on CH:THC1
Cantor Fitzgerald
Cantor Fitzgerald
CHF197.03
Buy
Reiterated
04/30/26
Tenet Healthcare (THC) Receives a Buy from Cantor Fitzgerald
Guggenheim Analyst forecast on CH:THC1
Guggenheim
Guggenheim
CHF227.58CHF202.65
Buy
Reiterated
04/30/26
Tenet Healthcare price target lowered to $252 from $283 at GuggenheimTenet Healthcare price target lowered to $252 from $283 at Guggenheim
Wells Fargo Analyst forecast on CH:THC1
Wells Fargo
Wells Fargo
CHF213.11
Buy
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Tenet Healthcare (THC)
Mizuho Securities Analyst forecast on CH:THC1
Mizuho Securities
Mizuho Securities
CHF188.98CHF213.11
Buy
Reiterated
03/12/26
Tenet Healthcare price target raised to $265 from $235 at MizuhoTenet Healthcare price target raised to $265 from $235 at Mizuho
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CH:THC1
RBC Capital
RBC Capital
CHF189.79
Buy
Reiterated
07/09/26
Tenet Healthcare (THC) Gets a Buy from RBC Capital
Bank of America Securities Analyst forecast on CH:THC1
Bank of America Securities
Bank of America Securities
Buy
Reiterated
07/08/26
Analysts Are Bullish on Top Healthcare Stocks: Tenet Healthcare (THC), Opus Genetics (IRD)
Barclays
CHF191.4CHF193
Buy
Reiterated
07/08/26
Tenet Healthcare price target raised to $240 from $238 at BarclaysTenet Healthcare price target raised to $240 from $238 at Barclays
TD Cowen
CHF187.38
Buy
Assigned
06/25/26
TD Cowen Remains a Buy on Tenet Healthcare (THC)
Morgan Stanley Analyst forecast on CH:THC1
Morgan Stanley
Morgan Stanley
CHF204.26
Buy
Reiterated
06/15/26
Analyst Maintains Buy on Tenet Healthcare, Reaffirming Unchanged $254 Price Target Amid Favorable Risk-Reward Setup
J.P. Morgan Analyst forecast on CH:THC1
J.P. Morgan
J.P. Morgan
CHF225.17CHF209.09
Buy
Reiterated
05/22/26
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
Robert W. Baird Analyst forecast on CH:THC1
Robert W. Baird
Robert W. Baird
CHF197.03CHF168.88
Hold
Reiterated
05/05/26
Tenet Healthcare price target lowered to $210 from $245 at BairdTenet Healthcare price target lowered to $210 from $245 at Baird
Stephens Analyst forecast on CH:THC1
Unknown Analyst
Stephens
Not Ranked
Stephens
CHF209.09
Buy
Reiterated
05/04/26
Stephens Remains a Buy on Tenet Healthcare (THC)
Truist Financial Analyst forecast on CH:THC1
Truist Financial
Truist Financial
CHF217.13
Buy
Reiterated
05/04/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Kymera Therapeutics (NASDAQ: KYMR)
Goldman Sachs Analyst forecast on CH:THC1
Goldman Sachs
Goldman Sachs
CHF213.11CHF202.65
Buy
Reiterated
05/03/26
Goldman Sachs Reaffirms Their Buy Rating on Tenet Healthcare (THC)
KeyBanc
CHF201.05CHF180.94
Buy
Reiterated
05/01/26
Tenet Healthcare price target lowered to $225 from $250 at KeyBancTenet Healthcare price target lowered to $225 from $250 at KeyBanc
Cantor Fitzgerald Analyst forecast on CH:THC1
Cantor Fitzgerald
Cantor Fitzgerald
CHF197.03
Buy
Reiterated
04/30/26
Tenet Healthcare (THC) Receives a Buy from Cantor Fitzgerald
Guggenheim Analyst forecast on CH:THC1
Guggenheim
Guggenheim
CHF227.58CHF202.65
Buy
Reiterated
04/30/26
Tenet Healthcare price target lowered to $252 from $283 at GuggenheimTenet Healthcare price target lowered to $252 from $283 at Guggenheim
Wells Fargo Analyst forecast on CH:THC1
Wells Fargo
Wells Fargo
CHF213.11
Buy
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Tenet Healthcare (THC)
Mizuho Securities Analyst forecast on CH:THC1
Mizuho Securities
Mizuho Securities
CHF188.98CHF213.11
Buy
Reiterated
03/12/26
Tenet Healthcare price target raised to $265 from $235 at MizuhoTenet Healthcare price target raised to $265 from $235 at Mizuho
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tenet Healthcare

3 Months
Success Rate
20/26 ratings generated profit
77%
Average Return
+7.93%
Copying Andrew Mok CFA's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +7.93% per trade.
1 Year
Ben HendrixRBC Capital
Success Rate
19/21 ratings generated profit
90%
Average Return
+37.80%
Copying Ben Hendrix's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +37.80% per trade.
2 Years
Ben HendrixRBC Capital
Success Rate
21/21 ratings generated profit
100%
Average Return
+64.86%
Copying Ben Hendrix's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +64.86% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THC1 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
25
24
16
16
15
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
24
17
17
16
In the current month, THC1 has received 15 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. THC1 average Analyst price target in the past 3 months is 198.08.
Each month's total comprises the sum of three months' worth of ratings.

THC1 Financial Forecast

THC1 Earnings Forecast

Next quarter’s earnings estimate for THC1 is $3.41 with a range of $2.89 to $4.18. The previous quarter’s EPS was $3.90. THC1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.
Next quarter’s earnings estimate for THC1 is $3.41 with a range of $2.89 to $4.18. The previous quarter’s EPS was $3.90. THC1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.

THC1 Sales Forecast

Next quarter’s sales forecast for THC1 is $4.39B with a range of $4.29B to $4.49B. The previous quarter’s sales results were $4.34B. THC1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.
Next quarter’s sales forecast for THC1 is $4.39B with a range of $4.29B to $4.49B. The previous quarter’s sales results were $4.34B. THC1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.

THC1 Stock Forecast FAQ

What is CH:THC1’s average 12-month price target, according to analysts?
Based on analyst ratings, Tenet Healthcare Corp.’s 12-month average price target is 198.08.
    What is CH:THC1’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:THC1, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Tenet Healthcare Corp. a Buy, Sell or Hold?
        Tenet Healthcare Corp. has a consensus rating of Strong Buy, which is based on 13 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Tenet Healthcare Corp.’s share price target?
          The average share price target for Tenet Healthcare Corp. is 198.08. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $217.13 ,and the lowest forecast is $168.88. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Tenet Healthcare Corp.?
            Tenet Healthcare Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
              How can I buy shares of Tenet Healthcare Corp.?
              To buy shares of CH:THC1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.